Prophylactic measures such as vancomycin, povidone-iodine and saline irrigation yielded similar rates of periprosthetic joint infection and wound complications at 3 months for high-risk patients ...

Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

Antimicrobial resistance (AMR) data from 2012 through 2022 shows that the number of drug-resistant infections in hospitals has largely gone down, though it is still significant, according to a study ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

A recent CDC study found that the rate of drug-resistant infections fell by about 30,000 between 2017 and 2022, but the change was dependent on the hospital. The study, published March 14 in JAMA ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

The study, conducted by researchers with the Centers for Disease Control and Prevention (CDC), found that six bacterial ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality ...